BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/20/2015 5:38:00 PM | Browse: 1458 | Download: 3158
 |
Received |
|
2014-11-12 08:06 |
|
Peer-Review Started |
|
2014-11-15 13:49 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-12-28 18:59 |
|
Revised |
|
|
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2015-01-16 10:12 |
|
Second Decision by Editor-in-Chief |
|
2015-01-16 15:23 |
|
Final Decision by Editorial Office Director |
|
2015-01-21 17:03 |
|
Articles in Press |
|
2015-01-21 17:29 |
|
Edit the Manuscript by Language Editor |
|
2015-04-20 03:48 |
|
Typeset the Manuscript |
|
2015-06-05 09:53 |
|
Publish the Manuscript Online |
|
2015-06-20 17:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Randomized Controlled Trial |
| Article Title |
Recombinant streptokinase vs hydrocortisone suppositories in acute hemorrhoids: A randomized controlled trial
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Francisco Hernández-Bernal, Georgina Castellanos-Sierra, Carmen M Valenzuela-Silva, Karem M Catasús-Álvarez, Osmany Martínez-Serrano, Odalys C Lazo-Diago, Cimara H Bermúdez-Badell, José R Causa-García, Juan E Domínguez-Suárez and Pedro A López-Saura; THERESA-4 (Treatment of HEmorrhoids with REcombinant Streptokinase Application) Group of Investigators |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Heber Biotec, Havana |
|
|
| Corresponding Author |
Francisco Hernández-Bernal, MD, MSc, Clinical Research Direction, Center for Genetic Engineering and Biotechnology, P.O. Box 6162, Havana 74110, Cuba. hernandez.bernal@cigb.edu.cu
|
| Key Words |
Streptokinase; Suppository; Hydrocortisone acetate; Thrombolysis; Hemorrhoids; Randomized clinical trial |
| Core Tip |
Medical treatments for acute hemorrhoidal disease come very seldom from randomized, controlled clinical trials. The paper describes that recombinant streptokinase suppositories, a candidate to a new therapeutic alternative, based on thrombolysis, shows significant efficacy advantage with respect to hydrocortisone acetate, a widely used, over-the-counter product. |
| Publish Date |
2015-06-20 17:38 |
| Citation |
Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-Álvarez KM, Martínez-Serrano O, Lazo-Diago OC, Bermúdez-Badell CH, Causa-García JR, Domínguez-Suárez JE, López-Saura PA; THERESA-4 (Treatment of HEmorrhoids with REcombinant Streptokinase Application) Group of Investigators. Recombinant streptokinase vs hydrocortisone suppositories in acute hemorrhoids: A randomized controlled trial. World J Gastroenterol 2015; 21(23): 7305-7312
|
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i23/7305.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i23.7305 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
